↓ Skip to main content

Muscle relaxants for pain management in rheumatoid arthritis

Overview of attention for article published in Cochrane database of systematic reviews, January 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
36 tweeters
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
137 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Muscle relaxants for pain management in rheumatoid arthritis
Published in
Cochrane database of systematic reviews, January 2012
DOI 10.1002/14651858.cd008922.pub2
Pubmed ID
Authors

Bethan L Richards, Samuel L Whittle, Rachelle Buchbinder

Abstract

Pain management is a high priority for patients with rheumatoid arthritis (RA). Muscle relaxants include drugs that reduce muscle spasm (for example benzodiazepines such as diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan) and non-benzodiazepines such as metaxalone (Skelaxin) or a combination of paracetamol and orphenadrine (Muscol)) and drugs that prevent increased muscle tone (baclofen and dantrolene). Despite a paucity of evidence supporting their use, antispasmodic and antispasticity muscle relaxants have gained widespread clinical acceptance as adjuvants in the management of patients with chronic musculoskeletal pain.

Twitter Demographics

The data shown below were collected from the profiles of 36 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
United Kingdom 1 <1%
Peru 1 <1%
Sri Lanka 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 131 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 15%
Student > Ph. D. Student 16 12%
Student > Bachelor 16 12%
Student > Doctoral Student 15 11%
Student > Postgraduate 13 9%
Other 29 21%
Unknown 27 20%
Readers by discipline Count As %
Medicine and Dentistry 51 37%
Nursing and Health Professions 14 10%
Psychology 12 9%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Neuroscience 3 2%
Other 8 6%
Unknown 39 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 November 2019.
All research outputs
#624,079
of 13,906,814 outputs
Outputs from Cochrane database of systematic reviews
#1,940
of 10,752 outputs
Outputs of similar age
#6,904
of 210,215 outputs
Outputs of similar age from Cochrane database of systematic reviews
#86
of 527 outputs
Altmetric has tracked 13,906,814 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,752 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.4. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,215 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 527 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.